Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil
Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil have?
Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil has 30 citations in the OpenAlex counts ScholarIQ stores.
When was Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil published?
Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil has 2018 year in the ScholarIQ index.
What is the open-access status of Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil?
Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil has closed oa status in the ScholarIQ index.
What is the DOI of Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil?
The DOI for Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil is on the source record.
What is the PMID of Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil?
The PMID for Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil is on the source record.
What is the OpenAlex record for Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil?
The OpenAlex for Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil is on the source record.